Bertis Supports the 9th Annual Kimchi-Making Donation Event Hosted by the Union of Korea Breast Cancer Patient

- Sharing warmth this winter by delivering homemade kimchi to more than 300 breast cancer patients nationwide

[Photo] Bertis employees participate in making kimchi with volunteers at the “9th Annual Kimchi-Making Donation Event” in Icheon, Gyeonggi Province.

Bertis, a proteomics-based precision medicine company (co-CEOs Dong-young Noh and Seung-man Han), announced that it supported the “9th Annual Nationwide Kimchi-Making Donation Event for Breast Cancer Patients,” organized by the Union of Korea Breast Cancer Patient (UKBCP). 

UKBCP is a non-profit organization registered under the Ministry of Health and Welfare dedicated to protecting the rights and improving the quality of life of breast cancer patients. The organization runs patient community groups, operates rest shelters, and offers various welfare support services. As part of its ongoing patient support efforts, this year’s kimchi-making event was held on November 18–19 at the UKBCP shelter in Icheon, Gyeonggi Province. Kimchi prepared directly by UKBCP members and volunteers was delivered to more than 300 breast cancer patients nationwide to help them prepare for the winter season. 

Through this sponsorship, Bertis supported the healthy recovery of breast cancer patients and contributed to a meaningful act of sharing. Bertis is the company behind MASTOCHECK®, the world’s first proteomics-based blood test for the early detection of breast cancer, and continues to engage in patient-focused initiatives alongside its technological advancements. 

Seung-Ran Choi, UKBCP President, said, “This kimchi donation event is more than just sharing food—it provides patients an opportunity to feel warmth and encouragement throughout their healing journey. Thanks to the interest and support from companies like Bertis, many patients will be able to spend this winter with comfort and hope.” 

Seung-man Han, CEO of Bertis, stated, “We are honored to join UKBCP in this meaningful event for breast cancer patients. As a biotech company, Bertis will continue to uphold its social responsibility and remain committed to supporting patients and contributing to a healthier society through various community initiatives.”